Michael A. Santoro
#102,743
Most Influential Person Now
Michael A. Santoro's AcademicInfluence.com Rankings
Download Badge
Economics
Michael A. Santoro's Degrees
- PhD Management Rutgers University
- Masters Business Administration Rutgers University
- Bachelors Economics Rutgers University
Similar Degrees You Can Earn
Why Is Michael A. Santoro Influential?
(Suggest an Edit or Addition)According to Wikipedia, Michael Anthony Santoro is a business ethicist and professor in the Department of Management and Entrepreneurship at the Leavey School of Business, Santa Clara University. Santoro has written and offered public comments on business and human rights, corporate social responsibility and human rights in China, pharmaceutical industry ethics, and Wall Street ethics. He was previously professor at Rutgers Business School.
Michael A. Santoro's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Pharmaceutical policy in China. (2008) (121)
- Profits and Principles: Global Capitalism and Human Rights in China (2000) (89)
- Ahoy There! Toward Greater Congruence and Synergy Between International Business and Business Ethics Theory and Research (2010) (72)
- Post-Westphalia and Its Discontents: Business, Globalization, and Human Rights in Political and Moral Perspective (2010) (50)
- China 2020: How Western Business Can—and Should—Influence Social and Political Change in the Coming Decade (2009) (43)
- Business and Human Rights in Historical Perspective (2015) (37)
- Beyond Codes of Conduct and Monitoring: An Organizational Integrity Approach to Global Labor Practices (2003) (34)
- Ethics and the Pharmaceutical Industry (2005) (32)
- The Importance of Value Diversity in Corporate Life (2003) (31)
- The ethics and economics of pharmaceutical pricing. (2015) (29)
- Wall Street Values: Business Ethics and the Global Financial Crisis (2012) (28)
- Overbooked and Overlooked: Machine Learning and Racial Bias in Medical Appointment Scheduling (2020) (21)
- Human rights obligations of drug companies (2020) (21)
- Pfizer: Global Protection of Intellectual Property (1992) (17)
- Strontium overload in uremic patients on regular dialytic treatment. (1986) (14)
- Editorial: Business and Human Rights Scholarship: Past Trends and Future Directions (2019) (9)
- Sears Auto Centers (A) (1993) (8)
- Profits and principles (2000) (6)
- Human Rights and Human Needs: Diverse Moral Principles Justifying Third World Access to Affordable HIV/AIDS Drugs (2006) (6)
- Pay Now, Lose Later: The Role of Bonuses and Non-Equity Incentives in the Financial Meltdown of 2007-2009 (2009) (5)
- Global Capitalism and the Road to Chinese Democracy (2000) (4)
- Should LDCs Love MNCs (2002) (4)
- Beech-Nut Nutrition Corporation (A-2) (1992) (4)
- The Regulatory and Ethical Challenges of Pediatric Research (2005) (3)
- Forging the New Salomon (1994) (3)
- Property Rights in Crisis: Managers and Rescue (2005) (3)
- Minnesota Mining and Manufacturing Company's hazardous waste program. (1978) (2)
- AIDS Activism and the Pharmaceutical Industry (2005) (2)
- A China Business Primer (2021) (2)
- Voting for your Boss: An Economic Argument for Workplace Democracy (2002) (2)
- Pharmaceutical Policy In China China's drug pricing reform needs to be implemented in coordination with hospital finance reform and health insurance expansion. (2008) (2)
- Soft Seat on the Long March: Foreign Business and the Rule of Law in China (2009) (1)
- Evolving Approaches to Healthcare Challenges (2005) (1)
- Business and Human Rights: From Principles to Practice , edited by Dorothée Baumann-Pauly and Justine Nolan. New York: Routledge, 2016. 329 pp. ISBN: 978-1138833586 (2017) (1)
- A Future Agenda for Government–Industry Relations (2005) (1)
- 4. China 2.0 Illusion and Promise behind the “Great Firewall” (2017) (1)
- Too Big and Too Interconnected to Fail: Historical and Ethical Analysis of Sustainability Risk to the U.S. Financial System (2012) (1)
- Why the United Nations is Not the Ideal Forum for Business and Human Rights: The UNGPs and the Right to COVID-19 Vaccine Access in the Global South (2021) (1)
- Wall Street Values (2012) (1)
- The Ethics of Insurance Industry Step Therapy Policies (2019) (0)
- Ethics and the Business of Biomedicine, ed. Denis G. Arnold. Cambridge: Cambridge University Press, 2009. Hardcover, 302 pp., $80. ISBN: 978-0521764315 (2009) (0)
- Wall Street Values: A Financial, Governmental, and Moral Crisis (2012) (0)
- Innovation in financial industry executive compensation practices: lessons of the ‘London Whale’ trade for Volcker Rule implementation (2015) (0)
- Mebel, Doran & Company Supplementary TN (1995) (0)
- Ethical Redress of Racial Inequities in AI: Lessons from Decoupling Machine Learning from Optimization in Medical Appointment Scheduling (2022) (0)
- Business and Human Rights: Quo Vadis? (2015) (0)
- Beyond face and guānxi (2021) (0)
- UN FORUM SERIES – “outside-in” and “inside-out” human rights measurement tools: how numbers can become the lingua franca of business and human rights (2015) (0)
- [Congenital leukemia (contribution of a case)]. (1973) (0)
- Wall Street Values: Wall Street Values for the Twenty-First Century (2012) (0)
- Note on Industry Self-Regulation and U.S. Antitrust Laws (1995) (0)
- Ethics and the Pharmaceutical Industry: Notes (2005) (0)
- 6. Conclusion The Two Chinas of 2020 (2017) (0)
- Asynchronous Political and Economic Development and the Asian Financial Crisis: A Preliminary Analysis (2003) (0)
- 3. Drug Safety Races to the Bottom The Need for “Safe Trade” in Drugs and Other Products Manufactured in China (2017) (0)
- Letters: Perfluorocarbon confusions (2001) (0)
- 1. Beyond the Shadow of Tiananmen The Role of Foreign Business in China’s Uncertain Path to Democracy and Human Rights (2017) (0)
- 2. The Clipboard, the Megaphone, and Socialist Characteristics Pragmatic and Ideological Approaches to Solving China’s Sweatshop Problem (2017) (0)
- Cultivating Ethical Agility (2021) (0)
- Cultivating Ethical Agility and employing guānxi to protect human rights (2021) (0)
- An Ethical Triad for Understanding Traditional Chinese Culture (2021) (0)
- Traditional Chinese Culture and Its Impact on Modern Business Ethics (2021) (0)
- Book Review: Ethics and the Pharmaceutical Industry (2006) (0)
- Wall Street Values: From Financial Services to Proprietary Trading (2012) (0)
- Wall Street Regulation for the Twenty-First Century (2012) (0)
- Ethics and Prescribing: The Clinician's Perspective (2005) (0)
- Wall Street Values: The Gathering Storm (2012) (0)
- Political Risk After the Asian Financial Crisis: A Proposal to Consider the Significance of Uneven Political and Economic Transformation (2002) (0)
- Leadership Problems at Salomon (A) (1994) (0)
- Tea with the dragon (2021) (0)
- Note on the Federal Sentencing Guidelines for Organizations and Corporate Criminal Fines Exercise TN (1995) (0)
- Acute kidney injury and early fluid load in a retrospective cohort of neonatal sepsis (2022) (0)
- INCINERATION OF INDUSTRIAL WASTES AT A LARGE MULTI-PRODUCT MANUFACTURING PLANT (2010) (0)
- Wall Street Values: Secrets and Lies (2012) (0)
- Reforming Financial Industry Executive Compensation Practices to Manage Risk, Build Long-Term Value, and Assure Legal Compliance: Lessons of the 'London Whale' Trade for Volcker Rule Implementation (2015) (0)
- Wall Street Values: Preface (2012) (0)
- LIST OF CONTRIBUTORS (1995) (0)
- Introduction to Part IV (2005) (0)
- Wall Street Values: Does Wall Street Have Any Responsibility to Society? (2012) (0)
- PATENTS, PRICING, AND EQUAL ACCESS (2005) (0)
- Wall Street Values: Notes (2012) (0)
- Ethics and the Pharmaceutical Industry: About the Editors (2005) (0)
This paper list is powered by the following services:
Other Resources About Michael A. Santoro
What Schools Are Affiliated With Michael A. Santoro?
Michael A. Santoro is affiliated with the following schools:
